AChE/BChE/BACE-1-IN-1 is an orally active inhibitor of AChE, BChE, and BACE-1, with potential therapeutic applications in Alzheimer's disease due to its strong binding to the peripheral anionic site (PAS) of AChE, good brain permeability, ability to disrupt Aβ aggregates, neuroprotective effects against Aβ-induced stress, and significant antioxidant potential.